News

Tandem Diabetes Care highlights potential for type 2 diabetes market growth with Control-IQ+
Tandem Diabetes Care achieves record Q1 2025 sales with 22% growth, launches Control-IQ+ for type 2 diabetes, doubling its market potential.
Kidney disease is the third-fastest-growing cause of death globally. Here's why doctors are sounding the alarm.
Compare Dialysis Centers examined CDC data and other sources to explore kidney disease risk factors and why the condition has ...